Eupraxia Pharmaceuticals Inc
TSX:EPRX

Watchlist Manager
Eupraxia Pharmaceuticals Inc Logo
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Watchlist
Price: 4 CAD 1.01% Market Closed
Updated: May 18, 2024

Eupraxia Pharmaceuticals Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Eupraxia Pharmaceuticals Inc
Pre-Tax Income Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Pre-Tax Income
-CA$28.9m
CAGR 3-Years
-93%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Pre-Tax Income
-$119.2m
CAGR 3-Years
13%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Pre-Tax Income
-$103.2m
CAGR 3-Years
-24%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Pre-Tax Income
-$94.1m
CAGR 3-Years
-8%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Pre-Tax Income
-$61.7m
CAGR 3-Years
21%
CAGR 5-Years
0%
CAGR 10-Years
-19%
Spectral Medical Inc
TSX:EDT
Pre-Tax Income
-CA$15.5m
CAGR 3-Years
-19%
CAGR 5-Years
-44%
CAGR 10-Years
-3%

See Also

What is Eupraxia Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
-28.9m CAD

Based on the financial report for Dec 31, 2023, Eupraxia Pharmaceuticals Inc's Pre-Tax Income amounts to -28.9m CAD.

What is Eupraxia Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-14%

Over the last year, the Pre-Tax Income growth was -21%. The average annual Pre-Tax Income growth rates for Eupraxia Pharmaceuticals Inc have been -93% over the past three years , -14% over the past five years .